Compounds > 2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose
Page last updated: 2024-09-05

2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose and swainsonine

2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose has been researched along with swainsonine in 1 studies

Compound Research Comparison

Studies
(2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose)		Trials
(2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose)		Recent Studies (post-2010)
(2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose)		Studies
(swainsonine)		Trials
(swainsonine)		Recent Studies (post-2010) (swainsonine)
10026147138

Protein Interaction Comparison

ProteinTaxonomy2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose (IC50)swainsonine (IC50)
Chain A, Alpha-mannosidase IiDrosophila melanogaster (fruit fly)0.02
Chain A, ALPHA-MANNOSIDASE IIDrosophila melanogaster (fruit fly)0.02
Chain A, Alpha-mannosidase IiDrosophila melanogaster (fruit fly)0.02
Lysosomal alpha-mannosidaseHomo sapiens (human)0.03
Alpha-mannosidase 2C1Rattus norvegicus (Norway rat)1.75
Mannosyl-oligosaccharide alpha-1,2-mannosidase IADrosophila melanogaster (fruit fly)0.005
alpha-1,2-Mannosidase Glycine max (soybean)0.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernacki, RJ; Dimitroff, CJ; Sackstein, R1

Other Studies

1 other study(ies) available for 2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose and swainsonine

ArticleYear
Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin.
    Blood, 2003, Jan-15, Volume: 101, Issue:2

    Topics: Acetylglucosamine; Antigens, Differentiation, T-Lymphocyte; Antigens, Neoplasm; Chemotaxis, Leukocyte; Glycosylation; Humans; Leukocyte Rolling; Lymphocytes; Membrane Glycoproteins; Polysaccharides; Skin Diseases; Structure-Activity Relationship; Swainsonine; Tunicamycin

2003